Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic maintenance dialysis

Clinica Chimica Acta

Volumn 312, Issue 1-2, 2001, Pages 69-79

  Ishii, Junnichi ^a   Nomura, Masanori ^a   Okuma, Toshio ^b   Minagawa, Taro ^b   Naruse, Hiroyuki ^a   Mori, Yoshihisa ^a   Ishikawa, Takashi ^c   Kurokawa, Hiroshi ^a   Hirano, Takahiro ^b   Kondo, Takeshi ^a   Nagamura, Youichi ^d   Ezaki, Kouji ^a   Hishida, Hitoshi ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hirano General Hospital   (Japan)

^c FUJITA HEALTH UNIVERSITY HOSPITAL   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Cardiac troponin; Chronic dialysis; Heart failure; Prognosis

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE; TROPONIN I; TROPONIN T;

ACUTE HEART FAILURE; ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; DIALYSIS; FEMALE; FOLLOW UP; HEART DEATH; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGED; ATRIAL NATRIURETIC FACTOR; CARDIOVASCULAR DISEASES; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; ROC CURVE; SURVIVAL RATE; TROPONIN I; TROPONIN T;

EID: 0034813110     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00592-7     Document Type: Article

References (56)

1. The prognostic value of serum troponin T in unstable angina
2. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I
3. Cardiac troponin T levels for risk stratification in acute myocardial ischemia
4. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
5. Improved troponin T ELISA specific for cardiac troponin T isoform: Assay development and analytical and clinical validation
6. Multicenter evaluation of a second-generation assay for cardiac troponin T
7. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina
8. Discordance between results for serum troponin T and troponin I in renal disease
9. Nonspecific elevation of troponin T levels in patients with chronic renal failure
10. Are cardiac troponins reliable serodiagnostic markers of cardiac ischaemia in end-stage renal disease?
11. Greater frequency of increased cardiac troponin T than increased cardiac troponin I in patients with chronic renal failure
12. Clinical specificity of a second-generation cardiac troponin T assay in patients with chronic renal failure
13. Developmental expression of troponin I isoforms in fetal human heart
14. Cardiac troponin I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue
15. Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle
16. Cardiac troponin T composition in normal and regenerating human skeletal muscle
17. Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: Evidence of cardiac troponin T expression in skeletal muscle
18. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim
19. Cardiac troponin T in end-stage renal disease patients undergoing chronic maintenance hemodialysis
20. Cardiac troponin T in patients with end-stage renal disease: Absence of expression in truncal skeletal muscle
21. Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: A 1-year outcomes analysis
22. Troponin T, a predictor of death in chronic haemodialysis patients
23. The predictive value of cardiac troponin T measurements in subjects on regular haemodialysis
24. Cardiac troponin elevations in chronic renal failure: Prevalence and clinical significance
25. Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: A 9-month outcome analysis
26. A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a Veteran's Hospital: A pilot study
27. Increased mortality in hemodialyzed patients with elevated serum troponin T: A one-year outcome study
28. Differential regulation of brain and atrial natriuretic peptide in hemodialysis patients
29. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure
30. Plasma concentration of human brain natriuretic peptide in patients on hemodialysis
31. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis
32. Changes of plasma atrial and brain natriuretic peptide levels during hemodialysis
33. Congestive heart failure in dialysis patients
34. The meaning and use of the area under a receiver operating characteristic (ROC) curve
35. A method of comparing the area under a receiver operating characteristic curves derived from the same case
36. Angiographic correlates of cardiac troponin T and I elevation in chronic hemodialysis patients
37. Increased cardiac troponin T and endothlin-1 concentration in dialysis patients may indicate heart disease
38. Clinical utility of cardiac troponin I and second-generation cardiac troponin T in hemodialysis patients
39. Hemodialysis impairs endothelial function via oxidative stress: Effects of vitamin E-coated dialyzer
40. Troponin T or troponin I or CK-MB (or none?)
41. Standardization activities of markers of cardiac damage: The need of a comprehensive approach
42. Cardiac troponin T and cardiac troponin I: Relative values in short-term risk stratification of patients with acute coronary syndromes
43. Cardiac troponin T predicts long-term outcomes in hemodialysis patients
44. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
45. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
46. Contribution of the kidney to metabolic clearance of atrial natriuretic peptide
47. No specific organ removes atrial natriuretic peptide from the human plasma
48. Predicting survival in adults with end-stage renal failure: An age-equivalence index
49. Clinical and echocardiographic cardiovascular disease in end-stage renal disease: Prevalence, associations and prognosis
50. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors
51. Current status of renal replacement therapy in Japan
52. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure
53. Effect of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSESUS)
54. Effect of captopril on mortality and survival in patients with reduced left ventricular ejection fractions and congestive heart failure
55. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
56. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure